Appendix 4C and Quarterly Update
444r10lc14lvz2
30 April, Top 20 Shareholders
Top_Holders_Report (2)
2017 to 2018 R&D Tax Rebate: $672k
2017:2018 $672k R&D Tax Rebate
Appendix 3B
Appendix 3B
11 April: Shortfall Placement Oversubscribed
190411_Shortfall Placement Oversubscribed
Change of Directors’ Interest: Appendix 3Y
190329_Directors Interest
Phase I Monepantel Tablets Demonstrate High Safety
190326_Scaled tablet single dose safety performance (clean)
Top 20 Shareholders, March 2019
PAA Top 20 as at 260319